PE20030239A1 - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents
Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animalesInfo
- Publication number
- PE20030239A1 PE20030239A1 PE2002000592A PE2002000592A PE20030239A1 PE 20030239 A1 PE20030239 A1 PE 20030239A1 PE 2002000592 A PE2002000592 A PE 2002000592A PE 2002000592 A PE2002000592 A PE 2002000592A PE 20030239 A1 PE20030239 A1 PE 20030239A1
- Authority
- PE
- Peru
- Prior art keywords
- mycoplasma bovis
- vaccine
- animals
- methods
- bovis
- Prior art date
Links
- 241001138504 Mycoplasma bovis Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 241001465754 Metazoa Species 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 206010035664 Pneumonia Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract 1
- 241000204003 Mycoplasmatales Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000001332 colony forming effect Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030239A1 true PE20030239A1 (es) | 2003-03-21 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000592A PE20030239A1 (es) | 2001-07-02 | 2002-07-01 | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (enExample) |
| EP (1) | EP1401488A1 (enExample) |
| JP (1) | JP2004536106A (enExample) |
| KR (1) | KR20040030783A (enExample) |
| CN (1) | CN1522152A (enExample) |
| AP (1) | AP2002002568A0 (enExample) |
| AR (1) | AR036125A1 (enExample) |
| BG (1) | BG108496A (enExample) |
| BR (1) | BR0210798A (enExample) |
| CA (1) | CA2452580A1 (enExample) |
| CZ (1) | CZ20033465A3 (enExample) |
| EA (1) | EA200301324A1 (enExample) |
| GT (1) | GT200200139A (enExample) |
| HN (1) | HN2002000162A (enExample) |
| HR (1) | HRP20031078A2 (enExample) |
| HU (1) | HUP0501188A2 (enExample) |
| IL (1) | IL159516A0 (enExample) |
| IS (1) | IS7078A (enExample) |
| MA (1) | MA27048A1 (enExample) |
| MX (1) | MXPA03011815A (enExample) |
| NO (1) | NO20035767L (enExample) |
| OA (1) | OA12640A (enExample) |
| PA (1) | PA8549801A1 (enExample) |
| PE (1) | PE20030239A1 (enExample) |
| PL (1) | PL373891A1 (enExample) |
| SK (1) | SK15802003A3 (enExample) |
| TN (1) | TNSN03154A1 (enExample) |
| UY (1) | UY27365A1 (enExample) |
| WO (1) | WO2003004052A1 (enExample) |
| YU (1) | YU102103A (enExample) |
| ZA (1) | ZA200309747B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| WO2008030619A2 (en) * | 2006-09-07 | 2008-03-13 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| MX2009001849A (es) | 2006-09-11 | 2009-03-02 | Pfizer Prod Inc | Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor. |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| NZ589981A (en) * | 2008-07-03 | 2012-11-30 | Univ Iowa State Res Found Inc | Cattle vaccines comprising a disrupted M. bovis bacterium |
| AU2009309041B2 (en) * | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| KR20170077255A (ko) | 2009-06-04 | 2017-07-05 | 고쿠리츠칸센쇼켄쿠죠 | 마이코플라즈마 감염증용 백신 |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| UA121193C2 (uk) | 2012-12-28 | 2020-04-27 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Спосіб одержання імуногенної композиції проти мікоплазми |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| CN108135989B (zh) | 2015-08-14 | 2022-08-09 | 硕腾服务有限责任公司 | 牛支原体组合物 |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| CA2390613A1 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Ceased
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-27 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Ceased
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN03154A1 (fr) | 2005-12-23 |
| HN2002000162A (es) | 2002-09-17 |
| HRP20031078A2 (en) | 2005-08-31 |
| MXPA03011815A (es) | 2004-04-02 |
| SK15802003A3 (sk) | 2005-01-03 |
| KR20040030783A (ko) | 2004-04-09 |
| WO2003004052A1 (en) | 2003-01-16 |
| BG108496A (en) | 2005-02-28 |
| IL159516A0 (en) | 2004-06-01 |
| JP2004536106A (ja) | 2004-12-02 |
| AR036125A1 (es) | 2004-08-11 |
| EA200301324A1 (ru) | 2004-12-30 |
| EP1401488A1 (en) | 2004-03-31 |
| HUP0501188A2 (en) | 2006-05-29 |
| NO20035767L (no) | 2004-01-30 |
| IS7078A (is) | 2003-12-15 |
| CA2452580A1 (en) | 2003-01-16 |
| BR0210798A (pt) | 2006-05-23 |
| US20030147914A1 (en) | 2003-08-07 |
| PA8549801A1 (es) | 2003-09-17 |
| MA27048A1 (fr) | 2004-12-20 |
| UY27365A1 (es) | 2003-04-30 |
| GT200200139A (es) | 2003-02-13 |
| PL373891A1 (en) | 2005-09-19 |
| ZA200309747B (en) | 2005-05-27 |
| CN1522152A (zh) | 2004-08-18 |
| YU102103A (sh) | 2006-05-25 |
| OA12640A (en) | 2006-06-15 |
| CZ20033465A3 (cs) | 2004-12-15 |
| AP2002002568A0 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030239A1 (es) | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales | |
| Jalava et al. | Bacterial ghosts as vaccine candidates for veterinary applications | |
| Fulton et al. | Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140 | |
| Glisson | Bacterial respiratory disease of poultry | |
| Roth | Mechanistic bases for adverse vaccine reactions and vaccine failures | |
| PE20030285A1 (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| JP2004536106A5 (enExample) | ||
| KR101818901B1 (ko) | 돼지흉막폐렴균의 재조합 ApxIA, ApxIIA, ApxIIIA toxin의 N 또는 C 말단 분자 및 불활화 돼지흉막폐렴균을 이용한 돼지 흉막폐렴 백신 조성물 | |
| El-Naggar et al. | A novel locally prepared inactivated bivalent mycoplasma vaccine for chicken flocks in Egypt | |
| US20210369832A1 (en) | Vaccine for protection against streptococcus suis | |
| EP2062594A1 (en) | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same | |
| Söderlind et al. | Effect of parenteral vaccination of dams on intestinal Escherichia coli in piglets with diarrhea | |
| Abd El Fadeel et al. | Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus | |
| MX2011001910A (es) | Composicion inmunologica. | |
| RU2021112503A (ru) | Поливалентная вакцина против м. hyo и её применение | |
| EP3076997A1 (en) | Swine vaccine against prrs and lawsonia intracellularis | |
| JP2010510197A (ja) | ワクチンの製造のためのクロストリジウム・パーフリンジェンスｃ型細菌の使用 | |
| Kunu et al. | A bread‐based lyophilized C‐strain CSF virus vaccine as an oral vaccine in pigs | |
| Sarwar et al. | Factors affecting potency of Hemorrhagic septicemia vaccines | |
| AR009650A1 (es) | Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna. | |
| I EL-Hawary et al. | Immunological response of locally prepared oil adjuvanted pneumo-5 vaccine in calves | |
| RU2462263C2 (ru) | Применение бактерии clostridium perfringens типа с для производства вакцины | |
| Porter et al. | Elimination of Escherichia coli K88 adhesion determinant by antibody in porcine gut and mammary secretions following oral immunization | |
| Hassanzadeh et al. | A serological study of Newcastle disease in pre-and post-vaccinated village chickens in north of Iran | |
| Dhakarwal et al. | Comparative evaluation of protective efficacy of experimental inactivated vaccines against haemorrhagic septicaemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |